Terms: = Colorectal cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346
132 results:
1. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
[No Abstract] [Full Text] [Related]
2. Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.
Chen SH; Tse KP; Lu YJ; Chen SJ; Tian YF; Tan KT; Li CF
Cancer Med; 2024 Jun; 13(12):e7384. PubMed ID: 38895905
[TBL] [Abstract] [Full Text] [Related]
3. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
[TBL] [Abstract] [Full Text] [Related]
4. Safety of high-dose rate (hdr) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series.
Thomas H; Chen JJ; Abdul-Baki H; Sabbagh A; Shaheen H; Chau OW; Malik N; Ayoub A; Hassanzadeh C; Hsu IC; Mohamad O
Brachytherapy; 2024; 23(2):173-178. PubMed ID: 38160102
[TBL] [Abstract] [Full Text] [Related]
5. Aluminium bioaccumulation in colon cancer, impinging on epithelial-mesenchymal-transition and cell death.
Bonfiglio R; Sisto R; Casciardi S; Palumbo V; Scioli MP; Giacobbi E; Servadei F; Melino G; Mauriello A; Scimeca M
Sci Total Environ; 2024 Jan; 908():168335. PubMed ID: 37939965
[TBL] [Abstract] [Full Text] [Related]
6. Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients.
Zamani F; Khalighfard S; Kalhori MR; Poorkhani A; Amiriani T; Hosseinzadeh P; Esmati E; Alemrajabi M; Nikoofar A; Safarnezhad Tameshkel F; Alizadeh AM
Med Oncol; 2023 Sep; 40(10):302. PubMed ID: 37725175
[TBL] [Abstract] [Full Text] [Related]
7. Organ and Function Preservation in Gastrointestinal Malignancies.
Sur R; Than NW; Taggar A; Sripadam R; Sun Myint A
Clin Oncol (R Coll Radiol); 2023 Aug; 35(8):524-532. PubMed ID: 37357120
[TBL] [Abstract] [Full Text] [Related]
8. Intensification of Local Therapy With High Dose Rate, Intraoperative Radiation Therapy (hdr-IORT) and Extended Resection for Locally Advanced and Recurrent colorectal cancer.
Agas RAF; Tan J; Xie J; Van Dyk S; C H Kong J; Heriot A; Ngan SY
Clin Colorectal Cancer; 2023 Sep; 22(3):257-266. PubMed ID: 37100642
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological Features and Prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
10. gata3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.
Reiswich V; Schmidt CE; Lennartz M; Höflmayer D; Hube-Magg C; Weidemann S; Fraune C; Büscheck F; Möller K; Bernreuther C; Simon R; Clauditz TS; Blessin NC; Bady E; Sauter G; Uhlig R; Steurer S; Minner S; Burandt E; Dum D; Marx AH; Krech T; Lebok P; Hinsch A; Jacobsen F
Pathobiology; 2023; 90(4):219-232. PubMed ID: 36649695
[TBL] [Abstract] [Full Text] [Related]
11. Wnt Family Member 9b (Wnt9b) Is a Sensitive and Specific Marker for Triple-negative Breast Carcinoma Including Metaplastic Carcinoma.
Shaker N; Shafi S; Parkinson B; Chen W; Parwani AV; Ding Q; Li Z
Am J Surg Pathol; 2023 Jan; 47(1):47-54. PubMed ID: 36525542
[TBL] [Abstract] [Full Text] [Related]
12. Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives.
Fokas E; Glynne-Jones R; Fleischmann M; Piso P; Tselis N; Ghadimi M; Hofheinz RD; Rödel C
Cancer Treat Rev; 2023 Jan; 112():102490. PubMed ID: 36463667
[TBL] [Abstract] [Full Text] [Related]
13. Setd2 supports gata3
Ding Z; Cai T; Tang J; Sun H; Qi X; Zhang Y; Ji Y; Yuan L; Chang H; Ma Y; Zhou H; Li L; Sheng H; Qiu J
Nat Commun; 2022 Dec; 13(1):7468. PubMed ID: 36463230
[TBL] [Abstract] [Full Text] [Related]
14. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (hdr) brachytherapy of liver metastases.
Damm R; Pech M; Cavalli P; Haag F; Gylstorff S; Omari J; Thormann M; Seidensticker R; Ricke J; Seidensticker M; Relja B
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2815-2826. PubMed ID: 35596772
[TBL] [Abstract] [Full Text] [Related]
15. Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach.
Fleischmann M; Diefenhardt M; Trommel M; Scherf C; Ramm U; Chatzikonstantinou G; Fokas E; Rödel C; Tselis N
Strahlenther Onkol; 2022 Jul; 198(7):654-662. PubMed ID: 35445815
[TBL] [Abstract] [Full Text] [Related]
16. High dose rate brachytherapy in the management of anal cancer: A review.
Ali ZS; Solomon E; Mann P; Wong S; Chan KKW; Taggar AS
Radiother Oncol; 2022 Jun; 171():43-52. PubMed ID: 35381275
[TBL] [Abstract] [Full Text] [Related]
17. Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring gata3.
Wang M; Guo X; Yang M; Zhang Y; Meng F; Chen Y; Chen M; Qiu T; Li J; Li Z; Zhang Q; Xu F; Zhang H; Wang W
Biochem Pharmacol; 2022 May; 199():115025. PubMed ID: 35367196
[TBL] [Abstract] [Full Text] [Related]
18. Longitudinal Associations of Former and Current Alcohol Consumption with Psychosocial Outcomes among colorectal cancer Survivors 1-15 Years after Diagnosis.
Révész D; Bours MJL; Weijenberg MP; Mols F
Nutr Cancer; 2022; 74(9):3109-3117. PubMed ID: 35212245
[TBL] [Abstract] [Full Text] [Related]
19. TRPS1 Expression in Breast Carcinomas: Focusing on Metaplastic Breast Carcinomas.
Parkinson B; Chen W; Shen T; Parwani AV; Li Z
Am J Surg Pathol; 2022 Mar; 46(3):415-423. PubMed ID: 35175968
[TBL] [Abstract] [Full Text] [Related]
20. Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity.
Al-Obaidy KI; Saleeb RM; Trpkov K; Williamson SR; Sangoi AR; Nassiri M; Hes O; Montironi R; Cimadamore A; Acosta AM; Alruwaii ZI; Alkashash A; Hassan O; Gupta N; Osunkoya AO; Sen JD; Baldrige LA; Sakr WA; Idrees MT; Eble JN; Grignon DJ; Cheng L
Mod Pathol; 2022 Sep; 35(9):1279-1286. PubMed ID: 35152262
[TBL] [Abstract] [Full Text] [Related]
[Next]
